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Abstract 
 
Recent research suggests that anxiety disorders may be more common in later life than 
previously thought. Among other factors, the presence of comorbid mood disorders and 
medical illness confounds accurate assessment and diagnosis of these conditions in the 
elderly. There have been few studies, however, examining the structural relationships 
between anxiety and depression with older-adult samples, and even fewer have 
considered the effect of medical illness on these relationships. This study examined three 
established structural models of anxiety and depression, using a clinical sample of older 
adults seeking treatment in a primary-care setting (N = 2,163). It was hypothesized that 
the presence of comorbid medical illness would act as a moderating variable in 
evaluating the fitness of these models. Results indicated that a hierarchical model 
represented the most parsimonious fit to the full sample. Tests of factorial invariance 
revealed variance in model fit as a function of illness severity and threat, and as a 
function of illness chronicity and progressiveness. Specifically, the relationship of 
somatic symptoms to anxiety varied by combined severity/threat, as well as by 
chronicity/progressiveness. These findings support previous conceptualizations of the 
relationship between anxiety and depression. Implications of these results for taxonomy, 
assessment, and intervention are discussed.  
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 Structural Models of Comorbid Anxiety and Depression in a Primary-Care  Older Adult 
Sample:  Effect of Medical Illness Severity, Threat, Chronicity, and Progressiveness on 
Model Fit 
 In the literature regarding psychopathology in older adults, anxiety disorders have 
traditionally received less attention than have other disorder categories such as dementia 
and depression. Epidemiological studies based on currently accepted diagnostic criteria 
(i.e., recent revisions of the Diagnostic and Statistical Manual of Mental Disorders 
[DSM-III; DSM-III-R; DSM-IV; American Psychiatric Association, 1980/1987/1994) 
have generally found anxiety disorders to be less common among older adults (Regier et 
al., 1984/1990). Researchers of late, however, have identified higher rates of anxious 
symptomatology among the elderly, suggesting that anxiety among older adults may be 
more prevalent than previously thought (Lenze, Mulsant, Shear, Alexopoulous, & 
Reynolds, 2001; Lynch, Compton, Mendelson, Robins, & Krishnan, 2000; Wetherell, 
Gatz, & Pedersen, 2001). Anxiety in older adults is associated with higher utilization of 
healthcare services (Flint, 1999; Forsell and Winblad, 1998), greater physical disability 
(Lenze, Shear, Mulsant, & Reynolds, 2002), and increased risk of mortality from medical 
conditions such as heart disease (Blazer, 1997; Lenze et al., 2002). 
 Among older adults, recognition of both anxious symptoms and syndromes can be 
confounded by a number of factors. In the DSM, anxiety disorders (as well as many other 
mental disorders) are defined as discrete clusters of anxious symptoms (Maser & 
Cloninger, 1990). Many anxious symptoms are seen in a number of anxiety disorders, 
resulting in considerable overlap between the various anxiety disorders, as well as 
between anxiety and mood disorders, particularly unipolar depression. A number of 
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studies have established that comorbidity between anxiety and mood disorders is a 
relatively common presentation (Brown & Barlow, 1992; Brown, Campbell, Lehman, 
Grisham, & Mancill, 2001; Kessler, McGonagle, Zhao, Nelson, & Hughes, 1994;  
Sanderson, DiNardo, Rapee, & Barlow, 1990). Among older adults, anxiety disorders and 
depression co-occur with such frequency that some researchers consider the two to be 
virtually indistinct in this population (Rivas-Vasquez, Saffa-Biller, Ruiz, Blais, & Rivas-
Vasquez, 2004; Stanley & Beck, 2001). Subsyndromal anxiety symptoms are also 
common in the presentation of major depression, particularly in the elderly. Studies of 
subthreshold anxiety and depression have indicated prevalence rates two to four times as 
high as that of specific anxiety or depressive disorders. Studies focusing specifically on 
the elderly have noted that these patients present with subsyndromal anxiety and 
depression in primary-care settings three to six times more frequently than with either 
condition reaching DSM threshold criteria (Rivas-Vasquez et al., 2004). Other 
researchers have noted that ‘anxious depression’ appears to be the most common 
presentation of anxious symptomatology observed in primary care settings (Flint, 1999; 
Sable and Jeste, 2001). This observation is particularly germane to our discussion of late-
life anxiety, given the fact that older adults with anxious symptoms are more likely to 
present in a primary-care setting, attributing their somatic symptoms to medical etiologies 
(Stanley & Beck, 2001). 
The presence of medical illness further obstructs accurate assessment and 
diagnosis of anxious syndromes in the elderly. Anxiety symptoms and disorders often 
present as comorbid with medical and physical syndromes, or they may arise in response 
to the onset of medical illness. In these cases, anxiety can impact the presentation and 
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course of the disease, as well as presenting challenges for treatment (Pontillo, Lang, & 
Stein, 2002; Roy-Byrne and Katon, 2000). Comorbid anxiety is observed most often in 
diseases whose physiological symptom presentations are similar to somatic symptoms of 
anxiety, such as cardiac illness, chronic obstructive pulmonary disease (COPD), asthma, 
and gastrointestinal disorders (Roy-Byrne and Katon, 2000).  Also, many medical 
conditions produce anxiety symptoms in their own right, including cardiovascular 
disease, COPD, endocrine disorders, and neurological conditions such as strokes, 
Parkinson’s disease, and neurodegenerative disorders (Cohen, 1990; Lauderdale & 
Sheikh, 2003; Sheikh, 2003). Physiological symptoms such as heart palpitations, 
tachycardia, headaches, stomachaches, etc., are among the most common manifestations 
of anxiety (Small, 1997). As a result, anxious symptoms, syndromes, and disorders are 
commonly observed in the context of treatment for medical illnesses. It has been 
estimated that approximately one in every five patients in the primary care setting has a 
diagnosable anxiety disorder, indicating that accurate assessment and diagnosis of these 
disorders plays a major role in both medical and psychological outcomes for a significant 
number of patients in this setting. Nevertheless, psychiatric disorders, including anxiety 
disorders, are missed in as many as half of primary-care patients, resulting in elevated 
morbidity and mortality in both the psychiatric and medical illnesses, and over-utilization 
of already limited healthcare resources (Zajecka, 1997). This becomes even more 
apparent when it is noted that the majority of patients presenting with somatic symptoms 
in primary care are not found to have a physiological etiology for their symptoms. 
Consequently, elevated rates of specific anxiety disorders, particularly GAD and panic 
disorder, are observed in these patients (Roy-Byrne and Katon, 2000).  
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The presence of anxiety disorders in the context of medical illness is associated 
with a number of negative outcomes. Particularly with comorbid depression, anxiety in 
medically ill patients is associated with increased disability, higher utilization of 
healthcare services, and increased mortality (Cohen, 1990; Lenze et al., 2002). The 
association between anxiety and increased mortality is particularly apparent in 
cardiovascular illness, although more research is needed to understand the mechanisms 
involved. Lenze and his colleagues (2001/2002) have noted the dearth of studies of 
anxiety in the medically ill elderly, despite evidence linking depression to increased 
mortality in physical illness, as well as substantial evidence linking anxiety and 
depression in this population. 
Structural Models of Anxiety and Depression 
 As it was apparent that anxiety and depression frequently co-occur with one 
another, the need to understand the exact nature of their relationship with one another 
became increasingly salient to researchers. Theoretical perspectives on the relationship 
between depression and anxiety appear to converge with the evidence from genetic and 
neurobiological studies suggesting that both disorders share at least one common factor, 
while being differentiated by unique factors. Newer, more sophisticated psychometric 
approaches in the 80’s and early 90’s gave rise to structural models explaining the 
relationship of anxiety and depression. An early model, proposed by Tellegen (1985), 
posited that two related dimensions of affect, positive and negative, could be seen as an 
underlying framework for differentiating mood and anxiety disorders. Within Tellegen’s 
model, positive affect was seen to be a specific factor in depression, while negative affect 
represented a general factor seen in both depression and anxiety. The model was 
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consistent with Beck’s content-specificity theory of psychopathology, in which 
depression contains both negative attributions about the future and ruminations about past 
events (Beck & Emery, 1985).  
 Building on Tellegen’s work and others, Clark and Watson (1991) conducted a 
review of factor analytic studies, which identified two specific factors in addition to the 
general distress factor; first, a factor consisting primarily of symptoms of autonomic 
arousal, relatively specific to anxiety, and an anhedonic (or low positive affect) factor 
which was unique to more severe depression. Consequently, the authors proposed a 
tripartite model of anxiety and depression that accounts for the generalized negative 
affect factor shared by both anxiety and depression, differentiating anxiety disorders by 
the presence of physiological arousal and depressive disorders by the lack of positive 
affect. In a series of tests, the authors built initial support for the validity of the model in 
student, adult, and patient clinical samples (Watson, Clark, et al., 1995).  
 Subsequent studies found support for the tripartite model in clinical samples of 
children and adolescents (Chorpita, Albano, and Barlow, 1997; Joiner, Catanzaro, and 
Laurent, 1996) as well as cross-cultural samples (Kiernan et al., 2001). Other studies 
have addressed the issue raised by Watson, Clark et al. (1995) regarding the validity of 
self-report measures, employing clinical interviews and psychophysiological studies (for 
a review, see Mineka et al., 1998) in addition to self-reports. However, Burns and 
Eidelson (1998) raised concerns about the validity of the tripartite model. In testing 
various structural equation models on student, substance-using, and adult outpatient 
samples, they found that a model containing two higher-order factors representing 
depression and anxiety provided the best fit for each sample group. As a result, Burns and 
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Eidelson argued that depression and anxiety were phenomenologically distinct constructs 
that could not be accounted for by a single distress factor. They acknowledged, however, 
that the high correlations between depression and anxiety could be the result of a single 
factor that would be undetectable to cross-sectional data. Earlier perspectives on the 
relationship between anxiety and depression also alluded to the temporal sequencing of 
the two disorders (see Alloy et al, 1990), further pointing out the need for longitudinal 
studies.  
 Applying evidence from previous diathesis-stress models of the development of 
anxiety disorders, Barlow and his colleagues (Barlow, 2002; Zinbarg et al., 1994, Zinbarg 
and Barlow, 1996) developed a three-factor model of anxiety disorders that had many 
similarities to the tripartite model. The most striking similarity between the two models 
was the appearance of a general factor, which Barlow labeled as ‘anxious apprehension’ 
that accounted for the shared variance among the anxiety disorders. Specifically, 
Barlow’s model proposed that anxious apprehension was a precursor to the development 
of all anxiety disorders. Each individual disorder, in turn, was differentiated by various 
biopsychosocial factors unique to the disorder. Most of the differences between the 
Barlow model and Watson and Clark’s model were, in fact, lexical differences. However, 
one important difference between the two was in the way the general distress/anxious 
apprehension factor was conceptualized. Although the shared and unique factors in the 
tripartite model were characterized as three first-order factors, Barlow’s model posits that 
the anxious apprehension factor (which Barlow would describe as negative affect in later 
papers) is a higher-order trait factor, representing a common vulnerability to both mood 
and anxiety disorders (Zinbarg and Barlow, 1996). In a preliminary test of this model 
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using a sample group of outpatients seeking treatment for anxiety symptoms (N = 432), 
confirmatory factor analysis produced six lower-order orthogonal factors which roughly 
corresponded to the six DSM-IV disorders diagnosed in the sample group. Additionally, a 
single higher-order factor emerged, correspondent to the common negative affect factor 
seen in other three-factor models. Secondary analyses revealed that the general negative 
affect factor could not be entirely accounted for by shared variance among the lower-
order factors or diagnostic overlap, lending further support to the validity of negative 
affect as a higher-order trait vulnerability (Barlow, 2002; Zinbarg and Barlow, 1996). 
 By now, it has become clear that the earlier models of anxiety and depression 
offered good explanations of some aspects of the relationships, while falling short in 
other areas (Mineka et al., 1997). The construct of negative affect as a common factor to 
both anxiety and depression, for example, has been supported in tests of both the tripartite 
and hierarchichal three-factor models (Watson et al., 1995; Zinbarg and Barlow, 1996). 
However, it is increasingly clear that the various anxiety disorders are differentially 
related to each other, as well as to depression. It is also apparent from the work of Barlow 
and his colleagues that the physiological arousal component of the tripartite model is not 
sufficient to discriminate all the anxiety disorders. In an exemplary study, Brown, 
Chorpita, and Barlow (1998) tested several structural models of anxiety and depression 
on a sample group of outpatients presenting with anxious and depressive symptoms (N = 
350). They found that the DSM-IV disorders identified in the sample group exhibited 
good discriminant validity. They also found, in accordance with the tripartite model, that 
each of the disorder factors was highly correlated to the negative affect factor, and that 
depression was inversely correlated to positive affect. However, they also found that 
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social phobia was similarly correlated to positive affect. Even more compelling, they 
found that the autonomic arousal factor, which was hypothesized by the tripartite model 
to differentiate anxiety disorders in general from depressive disorders, was in fact 
differentially related to each of the anxious syndromes. It exhibited the strongest 
relationship to panic disorder (r = .67), and had an inverse correlation to GAD (r = -.22). 
In the final model, however, autonomic arousal exhibited virtually no relationship to 
either social phobia or OCD, supporting Barlow’s view that each of the anxiety disorders 
has a unique component that differentiates it from the others.  
 In light of this evidence, Mineka and her colleagues (1998) proposed an 
integrative hierarchical model of anxiety and depression that incorporates empirically 
supported features of both the tripartite and hierarchical models proposed previously. 
This integrative model retains negative affect as a general distress factor common to 
anxiety and depression, and further posits that negative affect may play a pervasive role 
in a number of additional syndromes as well. The model goes on to recognize the 
heterogeneity of unique components of each disorder, calling for a better understanding 
of the nature of these factors. Finally, the integrative model points out that individual 
disorders may differ in the proportion of shared and unique factors observed in each 
syndrome. This observation has been noted in subsequent comorbidity research. For 
example, GAD and depression have been found to have a shared diathesis, while their 
environmental determinants are largely unique (Brown, Campbell, Lehman, Grisham, 
and Mancill, 2001). 
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Model Testing With Older Adult Samples 
 Although the existing models of anxiety and depression have been extensively 
researched in younger adult, child, and adolescent samples, there has been considerably 
less investigation of the validity of these models in older adults. A body of literature 
began to emerge in the 1990’s suggesting that older adults may experience affect 
differently than their younger counterparts, drawn primarily from studies of late life 
depression (Gurian and Miner, 1991; Shapiro, Roberts, and Beck, 1999). For example, a 
comparative factor analysis conducted with young (n = 207), middle age (n = 231), and 
older adult (n = 828) samples revealed that experiencing positive affect was less salient to 
older adults that to their younger counterparts, while the experience of anxiety in older 
adults was more directly related to fear than to other factors (e.g. guilt, shame, worry) 
that were more salient in the younger samples (Lawton, Kleban, and Dean, 1993). 
Nevertheless, only recently have researchers begun to test the established models of 
anxiety and depression in older adult samples. 
 Previous research employing younger adult samples had indicated that 
consideration of both cognitive and affective symptoms of anxiety and depression 
improves discrimination of each disorder (Jolly, Dyck, Kramer, and Wherry, 1994). In an 
attempt to determine whether the same held true in the elderly, Shapiro, Roberts, and 
Beck (1999) undertook an initial investigation of cognitive and affective structure of 
depression and anxiety in a sample of community-dwelling older adults (N = 283). They 
chose to simultaneously test Beck’s (1985) cognitive content-specificity hypothesis along 
with Watson, Clark, and Carey’s (1988) positive and negative affective model The 
researchers first performed a series of factor analyses on measures of anxiety and 
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depression that were theoretically based on each model. For the cognitive content-
specificity hypothesis, the Cognitions Checklist (CCL; Beck et al., 1987) was examined, 
and the Positive and Negative Affect Schedule (PANAS; Watson, Clark, and Tellegen, 
1998) was evaluated for affective structure. Factor analyses of the CCL with younger 
adult samples had produced a two-factor solution corresponding to the Depressive- and 
Anxious- Cognitions subscales contained in the measure (Beck et al., 1987; Steer, Beck, 
Clark, and Beck, 1994). In the older adult sample, however, the measure separated into 
three factors; a health-anxiety factor derived from the original CCL Anxiety Scale, and 
two separate depression factors, representing cognitions about declining social 
functioning and thoughts of low self-worth. A similar analysis of the PANAS scales 
maintained a two-factor solution similar to that suggested by Watson et al., although 
some individual items were excluded for lack of specificity. However, it should be noted 
that the items loading on the Negative Affect subscale were primarily associated with 
anxiety (e.g., ‘nervous,’ ‘jittery,’ ‘scared’), while items related to guilt and shame failed 
to load. This finding was consistent with those of Lawton et al. (1993) that ruminations 
about past events are less salient to elders than present concerns, particularly health-
related anxiety. 
 In the second set of analyses, the revised CCL and PANAS subscales were 
correlated with symptom measures of depression and anxiety to determine if the same 
correlations observed in younger samples would hold true in the older adult sample 
group. Subsequently, hierarchical multiple regressions were conducted to see if the CCL 
and PANAS subscales independently predicted anxiety and depressive symptoms. These 
analyses revealed stark differences between the older adult sample and younger adults. In 
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terms of cognitions, they found that anxious cognitions in older adults related to both 
anxious and depressive symptomatology, in contrast to younger samples where anxious 
cognitions specified anxious symptoms. Cognitions of worthlessness were also related to 
both anxious and depressive symptoms, while thoughts of social loss generally were not 
associated with either anxious or depressive symptomatology in the elderly sample group. 
By comparison, thoughts of negative self-worth in younger samples tended to be 
associated differentially with depression (Roberts and Gotlib, 1997). With regard to 
affect, although the Negative Affect factor was associated with general distress in the 
elderly sample, lack of positive affect did not differentiate between depressive and 
anxious symptom presentations. This study was limited in that 1) it relied mainly on self-
report measures, 2) the measures were completed in a group setting, which may have 
suppressed self-disclosure, and 3) the sample was relatively high-functioning, and 
generally asymptomatic. Nevertheless, the study suggested that older adults think 
differently about anxiety and depression than do their younger counterparts. Also, 
although the shared affective components of anxiety and depression may be similar 
across age groups, factors differentiating the disorders may vary as a function of 
advanced age.  
 Subsequent model tests of anxiety and depression in older adults have similarly 
failed to demonstrate invariance in factor structure between older and younger samples. 
Meeks, Woodruff-Borden, and Depp (2003) replicated Joiner’s (1996) test of one, two, 
and three-factor models of anxiety and depression, using a large (N = 1,429) randomly 
generated sample of older adults, as well as a smaller (N = 210) convenience sample of 
participants recruited from various community sites. In both samples, the researchers 
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found that a two-factor model provided the best explanation of the data, suggesting that 
the general distress factor observed in younger samples is qualitatively different from the 
experience of older adults. Wetherell, Gatz, and Pedersen (2001) also obtained a two-
factor solution in a longitudinal sample of middle-aged and older (M = 60.9 years) 
Swedish twins. Similar to Shapiro and her colleagues, these researchers found that 
general distress in older adults appeared to be more closely related to anxiety than to 
depression.  
One of the key limitations of Shapiro’s study, as well as many previous studies in 
this area, was the use of a relatively high-functioning, community-dwelling sample 
group. In their discussion, Shapiro and her colleagues rightly noted the possibility of a 
differential structure of anxiety and depression emerging in a sample of treatment-
seeking elders. Addressing this issue, J.G. Beck and her colleagues (2003) replicated 
Shapiro’s analysis of the CCL and PANAS with a sample of older adults presenting for a 
clinical trial of cognitive-behavioral therapy for GAD (N = 83). The researchers chose 
this relatively homogenous sample for two important reasons. First, they wished to avoid 
confounding their results through excessive variance in presentations, while still 
capturing a representative clinical sample. Citing earlier evidence of the wide prevalence 
of GAD in older adults, the authors argued that a sample group of GAD patients met this 
requirement. Second, the authors noted evidence that GAD itself may function as a 
higher-order factor in older adults, thus allowing them to extend the conceptualization of 
this syndrome in the elderly (Beck et al., 2003). The initial confirmatory factor analysis 
with the PANAS produced a three-factor solution, with negative affect separating into 
two factors. The two negative affect factors represented constructs similar to the findings 
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of Shapiro et al., with anxiety and anger loading on one factor and guilt and shame 
loading on the other. In Shapiro’s analysis, however, the guilt/shame items were dropped, 
leaving a two-factor model; in the Beck analysis, retention of the guilt/shame factor 
proved a better fit to the data. Exploratory and confirmatory factor analyses of the CCL 
items with this sample produced a two-factor solution, although there were notable cross-
loadings on several items. In contrast to Shapiro’s results, a three-factor solution did not 
improve model fit. Intercorrelations between the CCL and PANAS subscales, as well as 
between these subscales and established measures of depression and anxiety, supported 
convergent validity of the depression measures, while the anxiety subscales were less 
clearly convergent. Likewise, a series of hierarchical regressions found that the measures 
of depression added predictive power to the regression equations for anxiety, but the 
anxiety measures did not produce the same effect in predicting depression. Of particular 
note, each of the subscales of the cognitive and affective measures added significant 
predictive power to both state and trait anxiety measures, suggesting that long-standing 
generalized anxiety plays an etiological role in  the emergence of at least the anxious 
form of late-life depression (see Lynch et al., 2000, for a description). Overall, this study 
added to the growing evidence suggesting that older adults experience anxiety differently 
than their younger counterparts.  
There has been at least one direct test of a tripartite structural model of anxiety 
and depression undertaken in a clinical sample of older adults (Cook, Orvaschel, Simco, 
Hersen, and Joiner, 2004). This test also extended the existing literature by employing a 
structured interview measure, in addition to self-reports, to test the convergence of the 
tripartite model in a clinical outpatient sample of older adults (N = 131). Although the 
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results of this study supported adequate fit of the tripartite model, the authors noted that 
the physiological arousal factor, which is posited to be anxiety-specific, was significantly 
correlated with a measure of depressive symptoms (i.e., the BDI; r = .54, p = .001), as 
well as with SCID-IV diagnoses of depression (r = .47, p = .001). Consistent with Beck 
et al., (2003), as well as earlier theoretical perspectives on the temporal relationship 
between anxiety and depression (Alloy et al., 1990), these results suggest that generalized 
anxiety plays a role in anxiety, depression, and comorbid states in older adults, perhaps as 
a higher-order factor (Mineka, Clark, and Watson, 1998; Zinbarg and Barlow, 1996).  
Summary of the Present Literature 
The shortcomings of our current categorical system for classifying mental 
disorders are perhaps most glaring when it comes to differentiating between anxiety and 
depression. The presence of a great number of symptoms that are common to both 
anxious and depressive syndromes seems to argue for a nosology based on something 
other than discrete symptom clusters. Ironically, these very shortcomings have served to 
illuminate the shared variance of anxiety and mood disorders, and have formed the basis 
for development of theoretical models to address these issues. Improving differential 
diagnosis of anxiety and depressive disorders will necessitate development of 
psychometrically-sound and theoretically-grounded measures that represent the 
experience of anxiety and depression across multiple populations. This becomes 
particularly important in the context of late-life, given mounting evidence that older 
adults experience anxiety and depression differently than their younger counterparts. In 
the elderly, symptom presentations become increasingly diffuse and somatic, giving rise 
to new dilemmas in diagnosis. Additionally, since most anxiety and mood disorders begin 
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earlier in life and increasing age is associated with declining recall, over-reliance on self-
report measures becomes increasingly problematic with this population. Clinician-
administered measures that are reliable and valid with older adults form an essential piece 
of the puzzle in understanding and recognizing anxiety disorders in older adults. These 
problems are often exacerbated in the elderly by the presence of medical illness. 
Anxiety associated with medical illness is a particularly common occurrence 
among the elderly (Sheikh, 2003). Epidemiological studies, as well as longitudinal data, 
have indicated that a significant proportion of persons with chronic medical conditions 
also meet criteria for an anxiety disorder. Since the majority of older Americans suffer 
from chronic medical illness, we can expect an increased prevalence of comorbid anxiety 
symptoms and disorders in this group (Hybels and Blazer, 2003; Nguyen, Goldberg, & 
Sheikh, 1999; Small, 1997). Anxiety symptoms and discrete disorders, while relatively 
uncommon in community-dwelling older adults, are much more prevalent in medically ill 
elders. This increased prevalence is associated with increased morbidity and mortality, 
particularly in the context of comorbid depression (Lenze et al., 2000). There are several 
confounding issues encountered in recognizing anxiety in the context of medical illness 
that are of particular importance to older adults. Cognitive decline, comorbid depression, 
pharmaceuticals, substance use, and cohort effects can all serve to produce or mask 
anxious symptoms in the elderly patient (Nguyen et al., 1999; Small, 1997). 
Nevertheless, there have been no examinations of the structure of anxiety and depression 
conducted with medically ill older adults. 
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Hypotheses 
 Previous examinations of the relationship between anxiety and depression in older 
adults have usually relied on convenience samples taken from community or clinical 
settings. These samples have typically been relatively high-functioning, medically 
healthy older adults, with relative homogeneity regarding pre-existing psychiatric 
diagnoses. This study extends the current literature by employing a medically 
heterogenous sample of elders presenting in primary-care medical settings. This approach 
addresses concerns expressed by others in this research area (see Cook et al., 2004) 
regarding inclusion of medical comorbidity as a needed extension of the current literature 
in late-life anxiety and mood disorder comorbidity. To this end, information on comorbid 
medical conditions in this sample was used to provide a basis for generation of 
subsamples that varied in medical illness severity, threat, chronicity, and progressiveness.  
 The study tested three models of anxiety and depression comorbidity, based on 
models that have previously been examined in relatively healthy older-adult (Cook et al., 
2004; Meeks et al., 2003) and wider age-range adult (Burns & Eidelson, 1998) samples. 
This study examined the fit of each model to the overall sample, before examining 
whether the best-fitting of these models would prove invariant in subsamples defined by 
varying levels of medical illness severity, threat, chronicity, and progressiveness. The 
following hypotheses were proposed: 
1. A hierarchical model, with two first-order factors (representing depression and 
anxiety) subsumed under a higher-order, non-specific distress factor, will provide 
the best overall model fit. 
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2. The presence of medical illness is a moderating variable in the relationship 
between anxiety and depression in older adults. The structural model providing 
most parsimonious fit in the full sample (i.e., the hierarchical model) will prove 
non-invariant across subsamples representing various constructs of medical 
illness. Thus: 
(a) The hierarchical model will vary in fit between subsamples representing lower 
and higher levels of illness severity and threat. Severity is defined as the 
likelihood that participant medical conditions would require one or more days of 
hospitalization. Threat is defined as the likelihood that sequelae of present 
medical conditions would result in the death of the patient. 
(b) The model will vary in fit between subsamples representing lower and higher 
levels of illness chronicity and progressiveness. Chronicity is defined as the 
likelihood that participant medical illnesses will require medical treatment, 
beyond that which the participant could independently manage, for 6 months or 
longer. Progressiveness is defined as the likelihood that participant medical 
illnesses will increase in severity over time, regardless of treatment. 
Methods 
Participants 
 Participants for the study were derived from a sample group of older adults who 
originally participated in the Primary Care Research in Substance Abuse and Mental 
Health for the Elderly (PRISM-E; Levkoff, Chen, Coakley et al., 2004) multisite 
randomized trial of integrated behavioral healthcare for older adults. The sample group 
was derived from persons aged 65 years or older who originally presented at one of 34 
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primary care clinics across eleven sites participating in the PRISM-E study (N = 23,828). 
The study sites included six Department of Veterans’ Affairs Medical Centers (VAMC), 
three community health centers, and two urban hospital networks (Levkoff et al., 2004). 
Each potential participant completed a brief screening procedure, consisting of the12-
item General Health Questionnaire (GHQ-12; Goldberg & Williams, 1988) to assess 
symptoms of mental distress, two questions to assess suicidal thoughts (Spitzer et al., 
1994), and three questions regarding alcohol consumption (Sobell, Sobell, Leo, & 
Cancilla, 1988). 
 A total of 6,430 participants met initial screening criteria for the presence of 
psychological distress, suicidal ideation, or at-risk drinking. These participants were then 
invited to participate in a baseline assessment that included sections of the MINI 
International Neuropsychiatric Interview (MINI; Sheehan et al., 1998), the Center for 
Epidemiological Studies Depression Scale (CES-D; Radloff, 1997), and the Beck 
Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988), as well as measures of 
alcohol consumption and a medication review. Of those invited to participate, 3,225 
either declined to participate or were excluded because they were already receiving 
mental health or substance use treatment. Of the 3,205 participants who did participate in 
the baseline assessment, 992 did not meet baseline criteria for an anxiety, depressive, or 
substance use disorder, and were excluded on that basis. Additionally, 73 participants 
were excluded due to diagnoses of hypomanic or psychotic disorders, and 118 
participants did not complete the baseline assessment. Of the remaining 2,244 cases, 87 
were deleted listwise due to missing data on a MINI question about generalized anxiety 
that was to be used in the construction of the observed variables for the model. The 
remaining participants (N = 2,163) formed the sample group for the study. A frequency 
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comparison of key demographic variables between the excluded cases and those in the 
final sample revealed that the excluded participants were more likely to be black, 
between 65 and 74 years of age, never married, and more likely to report that they were 
just getting by financially (Table 1). Additionally, the final sample group was 
disproportionately male, which can probably be explained by the number of VAMC 
recruitment sites employed by the PRISM-E investigators. Comparison of the two groups 
on observed variables used in the models tested (Table 2) shows that the excluded 
participants generally reported higher levels of distress, although the groups were not 
statistically different from one another. 
Measures 
Mini International Neuropsychiatric Interview—The MINI International Psychiatric 
Interview (Sheehan, Lecrubier, Sheehan, et al. 1998) is a brief structured interview for 
diagnosis of DSM-IV and ICD-10 psychiatric disorders. The interview is organized in a 
series of 16 modules, representing various DSM-IV diagnostic categories (Table 3). Each 
module consists of a series of questions assessing current symptoms of each disorder that 
may be experienced by the patient.  The MINI has displayed adequate inter-rater and test 
retest reliability, and demonstrates good convergent validity with more comprehensive 
structured interviews (Lecrubier et al., 1997; Antony & Barlow, 2002). For this study, 
items derived from the modules representing anxiety and mood disorders were summed 
to construct observed variables representing subgroups of interest. (Table 4) 
Center for Epidemiological Studies Depression Scale (CES-D)----The CES-D (Radloff, 
1977) is a 20-item self report measure designed for use in epidemiological studies to 
screen for the presence of depressive symptomatology. It possesses good internal 
consistency (  = .85 [non-patients], .90 [patients]), and test-retest reliability (r > .54 at 6 
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months). Studies conducted with older-adult samples maintained similar numbers 
(Lewinsohn, Seeley, Roberts, & Allen, 1997). Radloff (1977) reported a consistent four-
factor structure (dysphoria, well-being, somatic complaints, and interpersonal difficulties) 
in factor analyses of the measure; this structure has been replicated in other studies as 
well (see Antony & Barlow, 2002). The CES-D appears to be an adequate screening 
instrument for depression, with good sensitivity; however, it has been noted that the CES-
D produces a high number of ‘false positives,’ limiting its diagnostic utility somewhat 
(Antony & Barlow, 2002). For this study, observed variables were constructed from the 
factors identified by Radloff (1977) as well as a summary of all measure items. 
Beck Anxiety Inventory (BAI)----The BAI (Beck, Epstein, Brown, & Steer, 1988) is a 21-
item self-report measure of anxiety severity.  It displays adequate internal consistency (α 
= .60) and good test-retest reliability (r [one week] = .75). Correlations with clinician-
administered anxiety scales were approximately .50, while correlations with clinician-
administered depression scales were lower (approximately .25). Antony & Barlow (2002) 
reported that factor analysis of the BAI with an adult outpatient sample produced a two-
factor solution (anxious cognitions and somatic arousal). This two-factor solution has 
also been observed in outpatient samples of older adults (Wetherell & Arean, 1997).  
These factors, as well as a summary variable, were employed to construct the observed 
BAI variables for this study.   
Physical Health Indicators—The PRISM-E baseline interview also gathered information 
regarding medical comorbidity. Participants in the baseline interview had an average of 
4.7 comorbid medical diagnoses (SD = 2.5; Levkoff et al., 2004). For purposes of 
invariance testing, the study employed self-reports from the PRISM-E baseline of 
medical diagnoses across 22 separate disease categories (Table 5). Each medical 
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diagnosis was assigned a separate weight for severity, threat, chronicity, and 
progressiveness based on mean ratings of each variable (Table 6) derived from a survey 
of nursing students enrolled in the MSN program at UM-St. Louis (N = 63). In this 
survey, the nursing students were asked to assign a rating to each of the 22 illness 
categories for each of the variables, using a 5-point Likert-type scale representing a 
percentage-range likelihood of each variable (see Appendix). Inter-rater agreement was 
adequate, with an intra-class correlation coefficient of 0.89 for the full survey. A series of 
Pearson product-moment correlations conducted between the four medical illnesses 
constructs on each category of medical illness revealed significant correlation between 
the severity and threat variables, as well as between the variables of chronicity and 
progressiveness.  Combining the ratings of severity and threat produced high item 
consistency (Cronbach’s ά = .917), with solid inter-rater reliability (Intraclass correlation 
coefficient = .917). Combining ratings for chronicity and progressiveness produced 
similar results (Cronbach’s ά = .897; intraclass correlation = .897) Variables representing 
these combined categories were computed using a weight for each medical illness created 
by summing the means for severity and threat, and summing the means for chronicity and 
progressiveness. Each illness category was multiplied by the combined weights, and the 
resulting sum of weighted illnesses was used to represent the constructs of severity/threat 
and chronicity/progressiveness.  
 
Descriptive Statistics 
 Correlational analysis of the observed variables for this study supported the utility 
of these variables in representing the latent variables of interest (Table 7). BAI factors 
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demonstrated the highest correlations with each other and with the MINI summed anxiety 
items. CES-D factor variables and MINI items representing factors associated with 
depression (summed depression, positive affect, negative affect) were also highly 
correlated with one another. Conversely, the BAI and MINI anxiety variables 
demonstrated clearly lower correlations with the CES-D and MINI depression variables. 
Compared to a community-dwelling sample of older adults (N = 281; Morin, Landreville, 
Colecchi, McDonald, Stone, & Ling, 1999), participants in this sample scored lower on 
the BAI subscales. This may reflect the fact that our sample group was predominantly 
(78.1%) male; older males have been shown to produce significantly lower BAI scores 
than older females (Owens, Hadjistavropoulos, & Asmundson, 2000). A recent validity 
study for the CES-D employing a sample of community-dwelling elders (N = 318; 
Haringsma, Engels, Beekman, & Spinhoven, 2004) recommended a cutoff score of 22 or 
above for diagnosing clinically significant symptoms of depression. In our study sample, 
50.7% of participants scored 22 or above on the CES-D. Compared to large 
epidemiological studies (for example, Zung, Broadhead, & Roth, 1993), this sample 
reported higher levels of clinically significant depressive symptoms; however, the 
presence of psychiatric symptomatology was an inclusion criteria for the original study. 




 To evaluate the question of whether medical illness would affect the structural 
relationship between anxiety and depression in this sample, an invariance-testing 
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approach was employed. To test invariance between the groups based on differences in 
medical illness severity and threat, the full sample was split into upper and lower thirds, 
using the summaries of medical comorbidities weighted by the combined severity/threat 
scores obtained from the nursing student survey. Factorial invariance was assessed by 
comparing model fit between the subgroups. A similar strategy was employed to test 
invariance between the groups based on chronicity/progressiveness. 
 For the tripartite model supported in the Cook et al. (2004) study, CES-D items 
loading on the ‘somatic’ factor and BAI items loading on the ‘somatic arousal’ factor 
were hypothesized to represent the latent ‘physiological hyperarousal’ variable. CES-D 
items loading on the ‘well-being’ factor and MINI items indicating positive affect were 
hypothesized to represent the latent ‘positive affect’ variable. The ‘negative affect’ latent 
variable was represented by CES-D items loading on the ‘dysphoria’ factor and BAI 
items loading on ‘anxious cognitions.’ The measurement/confirmatory model for the 
tripartite model appears in Figure 1.  
 For the hierarchical two-factor model from Burns & Eidelson’s (1998) study, the 
first-order ‘anhedonia’ factor was represented by CES-D items loading on the 
‘anhedonia’ and ‘somatic factors, and MINI items indicating positive affect. The ‘non-
specific depression’ factor was represented by CES-D ‘dysphoria’ items, and MINI items 
indicating summed depressive symptoms, as well as MINI negative affect items. The 
‘non-specific anxiety’ factor was represented by BAI items loading on the ‘anxious 
cognitions’ factor, and MINI items indicating both summed and non-specific symptoms 
of anxiety. The ‘somatic’ factor was represented by BAI items loading on the ‘somatic 
arousal’ factor and MINI items indicating physiological arousal. The measurement model 
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for the Burns-Eidelson model appears in Figure 2, with the structural model appearing in 
Figure 4.  
 For the hierarchical three-factor model from Meeks et al. (2003), the first-order 
‘depression’ factor was represented by CES-D well-being items and MINI items 
indicating depressive symptoms. The first-order ‘anxiety’ factor was represented by BAI 
and CES-D somatic subscales, BAI anxious cognitions, and the MINI items indicating 
anxious symptoms. The measurement model appears in Figure 3, with the structural 
model appearing in Figure 5. 
 Models were constructed and tested using AMOS (Analysis of Moment 
Structures) version 4.0 (Arbuckle, 1999). Chi-Square tests of model fit were employed as 
an initial assessment of model fit. Given the effect of large sample sizes on the chi-square 
distribution, additional fit indices were also examined. Absolute-fit indices, including the 
Goodness-of Fit Index (GFI; Hu & Bentler, 1995) and the Adjusted Goodness-of-Fit 
Index (AGFI; Hu & Bentler, 1995) were employed to address the sample size issue with 
the chi-square distribution, providing a comparison of fit between the hypothesized 
model and none at all. The AGFI provides an additional adjustment for degrees of 
freedom, affording a more specific test of model fit. The root-mean square error of 
approximation (RMSEA; Stieger & Lind, 1980) was also used to evaluate fit of these 
models. This measure of incremental fit provides a confidence interval around its point 
estimate, yielding further specificity of model fit (Smith & McMillan, 2001). 
Confirmatory factor analyses were conducted with each measurement model to evaluate 
adequate representation of each latent variable by the selected observed variables.  The 
CFA model for the tripartite model, along with the structural Burns-Eidelson and 
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hierarchical models, were then tested and compared for fit to the full (N = 2,163) PRISM-
E sample to test Hypothesis 1. 
 Based on the results of model testing with the full sample, the hierarchical model 
was selected for invariance testing with selected subgroups to evaluate Hypotheses 2(a 
and b). Model selection for this phase of analysis reflected adequate statistical model fit, 
as well as judgment of parsimony and theoretical congruence. The selected model was 
then tested for invariance, using the subsamples previously defined for each medical 
illness variable as well as the combination-weighted variables indicated by correlational 
analysis of the illness categories.  
Power Analysis 
 Ullmann (2001) provided a general estimate that sample sizes of > 200 are 
adequate for small to medium structural models. Based on this rough estimation, the 
proposed sample group appears to provide adequate power to test the proposed 
hypotheses. For a more exact analysis, we employed estimates provided by MacCallum, 
Browne, & Sugawara (1996) of sample size at p = .80 to detect an adequate root-mean 
square error of approximation (RMSEA). For the tripartite model, based on df = 25, a 
minimum sample size of N = 363 was estimated. For the Burns-Eidelson model, df = 10, 
requiring a minimum sample of N = 782. For the Meeks model, df = 15, and the 
recommended minimum sample (by extrapolation) is approximately N = 555. Given an 
overall sample of N = 2,163, employing upper and lower thirds produced subsamples 
with adequate sample size to evaluate each model with power exceeding 0.8.  
Results 
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 Confirmatory factor analysis of measurement models for each model revealed that 
the observed variables reliably measured the latent variables of interest (Table 9). All 
observed variables loaded significantly on their respective factors for each of the 
measurement models tested (p < .01). Testing of the full structural models revealed 
adequate statistical fit for both the tripartite and hierarchical (Meeks) models (tripartite 
model—χ2 (3) =  10.4, p = .0015; hierarchical-- χ2 (6) =  22.7, p < .001). The Burns-
Eidelson model did not demonstrate adequate fit to the full sample ( see Table 10 for 
additional fit indices).  
 The hierarchical model was chosen for testing of invariance on the medical-illness 
variables of interest. Although the tripartite model could be judged as parsimonious on 
the basis of fewer overall parameters, the observed variables in the hierarchical model 
appear to better represent the hypothesized latent variables. Also, more of the paths from 
latent to observed variables were free to vary in the hierarchical model, providing greater 
construct validity for that model. Finally, the hierarchical model was believed to best 
represent the theoretical relationship between the three factors, as the most recent models 
in the literature suggest negative affect is a higher-order factor common to both anxiety 
and depression, while low positive affect is more specific to depression and physiological 
arousal is more specific to anxiety (Mineka et al., 1998; Teachman, Siedlecki, & Magee, 
2007). 
 An invariance test using the combined severity-threat weighted summary of 
medical conditions revealed non-invariance between the low severity/threat (n = 705) and 
high severity/threat (n = 750) subsamples. Specifically, the BAI ‘somatic complaints’ 
items were differentially related to the anxiety variable between groups. An examination 
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of the regression paths revealed that the BAI somatic subscale was more highly 
correlated to the anxiety factor in the high severity/threat subsample (r = .57; Figure 6 ) 
than in the low severity/threat subsample (r = .25; Figure 7). A summary of the model-
fitting sequence to the severity/threat groups appears in Table 11. 
 An invariance test using the combined chronicity/progressiveness weighted 
summary of medical conditions revealed non-invariance between the low 
chronicity/progressiveness (n = 716) and high chronicity/progressiveness (n = 733) 
subsamples. Again, the BAI somatic complaint subscale was found to vary between 
groups. Examination of regression paths revealed that the correlation of the BAI somatic 
subscale with the anxiety factor was higher for the high chronicity/progressiveness group 
(r = .58; Figure 8) than for the low chronicity/progressiveness group (r = .25; Figure 9). 
A summary of the model-fitting sequence to the chronicity/progressiveness groups 
appears in Table 12. 
Discussion 
 The present study extends the current literature in several important ways. First, 
the study employed a sample group of older adults presenting in a primary-care setting. 
This corresponds to previous literature suggesting that older adults are more likely to 
present to primary-care providers with anxious and depressive symptoms than younger 
adults, who would be more apt to utilize specialty mental-health providers (e.g., Levkoff, 
Chen, Coakley et al., 2004; Bartels, Coakley, Zubritsky, et al., 2004). This approach, 
although technically a convenience sample, provides better external validity since it is 
selected on the basis of characteristics known to exist in the larger population. Further 
supporting the generalizability of these results, the sample group was drawn from a large 
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multisite clinical trial, with a range of both demographic characteristics and 
psychopathology generally reflective of a larger population. The large sample size 
provided adequate power to detect effects, both in the overall model-fit and in subsequent 
invariance testing. Most importantly, this sample included a range of comorbid medical 
conditions that allowed testing of factorial invariance on the basis of several important 
illness constructs.    
 In regard to the first hypothesis, the hierarchical model of comorbid anxiety and 
depression, with a second-order distress factor common to both conditions, provides 
adequate fit in the full sample. This extends the results found by Meeks et al. (2003) in 
probability and convenience samples to a larger, primary-care sample with information 
regarding a full range of comorbid medical illnesses. This study provides further support 
for the existence of a general-distress factor that underlies more specific expressions of 
psychopathology. Hierarchical models of this type have previously been fitted to discrete 
anxiety disorders (Zinbarg & Barlow, 1996) as well as anxiety and depression (Brown, 
Chorpita, & Barlow, 1998), and have been proposed to account for a wider range of 
psychopathology (Mineka, Watson, & Clark, 1998; Krueger, Markon, Chentsova-Dutton, 
Goldberg, & Ormel, 2003). Although the tripartite model adequately fit the sample as 
well, the hierarchical model was chosen for invariance testing on the basis of congruence 
with previous literature noting the differential relationship of negative affect to discrete 
anxiety disorders (Mineka, Watson, & Clark, 1998). Previous research has elucidated 
differences in the phenomenology of comorbid anxiety and depression in older adults; in 
particular, the prevalence of mixed anxiety-depressive states and subthreshold symptom 
presentations point to a common factor impacting both syndromes (Shapiro, Roberts, & 
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Beck, 1999; Rivas-Vasquez et al., 2004). A recent SEM examination of a tripartite model 
in a cross-sectional community sample of adults aged 18-93  (Teachman, Siedlecki, & 
Magee, 2007) posited a second-order negative-affect factor, similar to the models 
proposed earlier by Meeks et al. (2003), as well as by Zinbarg & Barlow (1996) and 
Mineka et al. (1998). This research suggests a continuing evolution toward 
conceptualization of negative affect as a higher-order factor common to anxiety and 
depression, and possibly to a number of other disorders as well. 
 The hierarchical model was found to vary between low and high-severity/threat 
subsamples, as well as between low and high-chronicity/progressiveness subsamples, in 
the relationship of somatic symptoms of anxiety to the latent anxiety variable. 
Specifically, somatic symptoms of anxiety were more strongly related to anxiety in the 
subsamples that were higher on each construct. This finding represents an important 
extension of the current literature, as it provides a better understanding of the impact of 
medical illness on the somatic expression of anxiety. Researchers have decried the lack of 
empirical data regarding this issue, arguing for the need of a better understanding of the 
presentation of anxiety in the context of medical illness (Farrell, 1997; House & Stark, 
2002; Harter, Conway, & Merikangas, 2003). 
 Awareness of the direct relationship of somatic symptoms of anxiety to illness 
severity, threat, chronicity, and progressiveness has a number of important implications 
for assessment and treatment approaches in elderly patients. In spite of long-established 
data suggesting that anxiety disorders are common in the elderly, development of reliable 
and valid measures for anxiety in the medically ill elderly has traditionally lagged behind 
development of measures for other disorders, particularly depression (Hersen, van 
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Hasselt, & Gorenczy, 1993; Neal & Baldwin, 1994). In fact, there is still no universally 
accepted measure of late-life anxiety in general that has been sufficiently validated with a 
representative sample of elders (Ayers, Sorrell, Thorp, & Wetherell, 2007). The 
variations in responding to the BAI somatic-symptom questions noted in this study 
concur with other researchers who have pointed out its lack of specificity in older-adult 
samples, stemming from its reliance on somatic symptoms which are often elevated in the 
medically ill elderly (Wetherell & Gatz, 2004). These results underscore the need for 
increased specificity in assessments for anxiety in the medically ill elderly. Given the 
evidence linking anxiety to increased morbidity and mortality in the medically ill elderly, 
the development of reliable, valid, and accessible measures for use in clinical practice 
should be prioritized (Kim, Braun & Kunik, 2001; Ball, Goddard & Shekhar, 2002;.Stein, 
Sherbourne, Craske et al., 2004). 
 In terms of developing interventions germane to older adults with medical 
comorbidity, results of this study failed to indicate significant differences between 
healthy and ill adults in the relationship of anxious cognitions to anxiety. This suggests 
that interventions targeting anxious cognitions, which have been shown to be generally 
effective in older-adult samples (Ayers, Sorrell, Thorp, & Wetherell, 2007) should be 
effective in those with medical comorbidities as well. The increased presence of somatic 
symptoms in the medically ill suggests that behavioral interventions for anxiety should be 
offered routinely in the course of medical treatment of illnesses known to show a higher 
association with anxious symptoms, such as cardiac disease and COPD. 
 Factorial invariance testing of the selected model raised several issues that had to 
be addressed. First, it was necessary to develop a reliable and valid measure of medical 
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illness that would serve as the basis for dividing the full sample into the groups upon 
which the model would be evaluated. One of the considerations that influenced selection 
of the PRISM-E dataset for this study was the availability of sufficient data on medical 
illness to allow construction of such a measure. In fact, the screening and baseline 
surveys included information on a variety of medical questions, including healthcare 
utilization, pharmaceutical usage, self-perceptions of physical health, functional health 
status, and comorbid medical conditions (see Levkoff et al., 2004, for a full description). 
 A number of potential strategies were considered for utilizing the available data to 
develop the medical-illness measure. One strategy involved using individual medical-
illness variables, such as the SF-36 Physical Health subscale, to increase power by 
allowing more of the sample group to be employed. However, each of the potential 
variables raised questions regarding its validity as a stand-alone indicator of medical 
illness. The SF-36 Physical Health subscale, for example, could be criticized for relying 
solely on self-reported perceptions of health. Reports of medication usage raised a similar 
issue of veracity as well as proving to be too heterogeneous to draw clear conclusions 
from. The Cornell Healthcare Utilization Scale measures hospital admissions and 
outpatient treatment utilization. This option would likely have produced a negatively 
skewed distribution of scores, given anecdotal reports that hospitalization generally 
implies an acute illness state (Lee, personal communication). This type of distribution 
would have failed to lend concurrent validity to the current approach, although the issue 
would have been a statistical one, rather than actual disconfirmation of the survey 
findings. 
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In an attempt to establish convergent validity, several strategies were explored 
that would combine the existing variables into a medical-illness severity or chronicity 
variable by employing an interaction or cross-tabulation strategy (for example, see 
Sheikh, Cassidy, Doriaswamy, et al. 2004). Unfortunately, employing such strategies 
with the study sample produced subsamples that lacked sufficient power to adequately 
test the proposed models. Therefore, the decision was made to utilize a single measure, 
the summed medical-illness checklist, to define the construct of interest. This strategy 
maximized statistical power by allowing use of the full sample. Simply summing the 
number of medical conditions present in participants, however, failed to provide 
information regarding the variables of interest in this study (i.e., illness severity, 
chronicity, progressiveness, and threat).  
 To address this issue, a weight was assigned to each medical condition in the 
sample, indicating the level of each variable of interest. A summary of each condition 
with the weights added would then allow assessment of severity, threat, chronicity, 
and/or progressiveness. It was suggested that these weights might be generated by 
obtaining a consensus rating of each illness category on the measures of interest by a 
sample of persons who could be considered to have authoritative knowledge regarding 
these medical conditions (Lee, personal communication, 2006). This strategy has been 
employed in similar studies where illness severity was a variable of interest (Farley & 
Hill, 2005; Chawistiak, Rosenheck,  McEvoy  et al.,2006). Physician rating of illness 
severity and chronicity forms the basis for well-established measures of illness severity 
and chronicity, such as the Cumulative Illness Rating Scale (Linn, Linn, & Gurel, 1968). 
A survey (see Appendix) was administered to a sample of masters-level nursing students, 
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who were considered to be familiar with both the disease categories in our checklist and 
the variables of interest. Tests of inter-rater reliability conducted with this sample 
indicated that the survey participants reached an acceptable level of agreement in rating 
the illness on each variable. However, the homogenous nature of the survey sample calls 
any statement of reliability into question. The nursing students surveyed primarily come 
from an acute-care hospital background. Nurses from other settings, such as long-term 
care or community practice, may produce very different ratings of these illnesses, based 
on their perspective (Steffen, personal communication). Healthcare professionals from 
other disciplines (e.g., medical doctors) and family caregivers may offer still more 
variation in ratings. Considering this variation in future studies would add external 
validity to our weights. This weighting system also limited the utility of our results in the 
sense that it rates levels of severity, threat, chronicity, and progressiveness by condition. 
However, this approach fails to account for individual differences between participants 
on the variables of interest. Cross-validation of this measure with SF-36 or Cornell Scale 
data would help to address this issue and lend a degree of concurrent validity to our 
assumptions regarding medical illness. 
 The decision to create variables based on combined constructs of severity/threat 
and chronicity/progressiveness was based on a series of Pearson product-moment 
correlations looking at the relationships between the four constructs within each illness 
category. Results of this analysis revealed high correlations between severity and threat 
ratings for each illness, as well as high correlation between chronicity and 
progressiveness ratings. One could conceptualize that the constructs of severity and threat 
might be related, as increases in severity of an illness would logically increase the threat 
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associated with the condition. Similarly, both chronicity and progressiveness refer to 
changes in the disease process over time. Diseases that are more likely to persist over 
time (chronic disease) could be expected to be more likely to increase in severity over 
time as well (progressive illness). Given the similarity of patterns of variance based on 
the combined weightings evaluated, it would be expected that invariance testing using 
weights based on each individual construct would yield similar results.  
 Although the nature of the sample group offers a number of advantages for the 
generalizability of our results, there are also several limiting factors to be noted. The 
sample group consisted of older adults who sought help at primary-care clinics, and who 
were willing to participate in the original study. While the literature suggests that primary 
care is a preferred point of contact for older adults, there may be qualitative differences 
between those elders who seek help in this manner and those who would present to other 
providers, such as mental health practitioners, clinics, and emergency rooms, as well as 
those who do not seek help for their symptoms. It is possible that those potential 
participants who declined to participate may also differ in important ways from those 
who did participate. Exclusion criteria for the final sample group limits the 
generalizability of the study at both ends of the spectrum of psychopathology. 
Participants who did not meet baseline criteria for anxiety, depressive, and substance use 
disorders were excluded from the original study. Thus, the study sample did not allow us 
to look at persons who exhibited subsyndromal anxiety and depressive symptoms. It is 
crucial to include these persons in future studies, given the prevalence of 
symptomatology in this population that falls short of DSM-IV diagnostic criteria, but 
nevertheless results in significant distress and impairment. Conversely, potential 
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participants who were already receiving treatment for an anxiety or mood disorder, or had 
diagnoses of hypomanic or psychotic disorders, were also excluded. This further 
restricted the range of psychopathology in the sample group. Additionally, the observed 
variables in our models were created by either employing existing factor analyses (in the 
case of the BAI and CES-D variables) or by summing MINI symptom questions 
associated with general anxiety and depression factors. This method does not provide 
information about the relationship of specific DSM disorders to the latent variables. 
Additionally, this method limits the validity of the latent variables to the reliability and 
validity of the observed measures. An important replication of this study would employ 
different measures to represent the latent variables. In particular, the measures selected 
should address some of the salient critiques of established symptom measures with older 
adults. For example, the BAI has often been criticized for its over-reliance on somatic 
symptoms of anxiety, which creates confounds when employed in chronically ill 
populations.  
 This study represents an important first step in elucidating the relationship 
between anxiety, depression, and comorbid medical conditions. It will be necessary, 
however, to replicate these findings in a sample that addresses the limitations of the 
current study. Also, these results are based on cross-sectional data. Examining these 
relationships in a longitudinal design is a needed extension of this research, to further 
clarify the nature of these relationships as medical illness persists and progresses. Future 
studies should employ observed variables that reflect specific factors and disorder 
criteria. Additionally, reliable and valid measures of the medical-illness constructs should 
be employed. Also, future studies should explore anxiety and depression comorbidity 
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within individual disease states. Finally, integrated models that specify the relationship 
between anxiety, depression, and medical illness should be posited and tested.  
Palmer, William Michael, 2007, UMSL      p. 42 
References 
 
American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental 
Disorders (3rd Ed.). Washington, DC:  American Psychiatric Press. 
American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental 
Disorders (3rd Ed., rev.). Washington, DC:  American Psychiatric Press. 
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental 
Disorders (4th Ed.). Washington, DC:  American Psychiatric Press.  
Antony, M., & Barlow, D.(Eds.) (2002). Handbook of Assessment and Treatment 
Planning for Psychological Disorders. New York:  Guilford. 
Arbuckle, J., (1999). AMOS: Analysis of moment structures (version 4.0). Chicago:  
SmallWaters. 
Ball, S., Goddard, A., & Shekhar, A. (2002). Evaluating and treating anxiety disorders in 
medical settings. Journal of Postgraduate Medicine, 48, 4, 317-321. 
Barlow, D. (2002). Anxiety and its Disorders:  The Nature and Treatment of Anxiety and 
Panic (2nd Ed.). New York:  Guilford. 
Bartels, S., Coakley, E., Zubritsky, C., Ware, J., Miles, K., Arean, P., et al. (2004). 
Improving access to geriatric mental health services:  A randomized trial 
comparing treatment engagement with integrated versus enhanced referral care 
for depression, anxiety, and at-risk alcohol use. American Journal of Psychiatry, 
161, 8, 1455-1462. 
Beck, A., & Emery, G. (1985). Anxiety disorders and phobias:  A cognitive perspective. 
New York:  Basic Books.  
Palmer, William Michael, 2007, UMSL      p. 43 
Beck, A., Brown, G., Steer, R., Eidelsen, J., & Riskind, J. (1987). Differentiating anxiety 
and depression:  A test of the cognitive content-specificity hypothesis. Journal of 
Abnormal Psychology, 96, 3, 179-183. 
Beck, A., Epstein, N., Brown, G., & Steer, R. (1988). An inventory for measuring 
anxiety:  Psychometric properties. Journal of Consulting and Clinical 
Psychology, 56, 893-897. 
Beck, J., Novy, D., Diefenbach, G., Stanley, M., Averill, P., & Swann, A. (2003) 
Differentiating anxiety and depression in older adults with generalized anxiety 
disorder. Psychological Assessment, 15, 184-192. 
Blazer, D. (1997). Generalized anxiety disorder and panic disorder in the elderly:  A 
review. Harvard Review of Psychiatry, 5, 18-27. 
Brown, T., & Barlow, D. (1992). Comorbidity among anxiety disorders:  Implications for 
treatment and DSM-IV. Journal of Consulting and Clinical Psychology, 60, 6, 
835-844. 
Brown, T., Chorpita, B., & Barlow, D., (1998). Structural relationships among 
dimensions of the DSM-IV anxiety and mood disorders and dimensions of 
negative affect, positive affect, and autonomic arousal. Journal of Abnormal 
Psychology, 107, 2, 179-192. 
Brown, T., Campbell, L., Lehman, C., Grisham, J., & Mancill, R. (2001). Current and 
lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large 
clinical sample. Journal of Abnormal Psychology, 110, 4, 585-599.  
Palmer, William Michael, 2007, UMSL      p. 44 
Burns, D., & Eidelson, R. (1998). Why are depression and anxiety correlated?  A test of 
the tripartite model. Journal of Consulting and Clinical Psychology, 66, 3, 461-
473. 
Clark, D., & Watson, L. (1991). Tripartite model of anxiety and depression:  
Psychometric evidence and taxonomic implications. Journal of Abnormal 
Psychology, 100, 3, 316-336. 
Cohen, G. (1990). Anxiety and general medical disorders. In C. Salzman & B. Lebowitz 
(Eds.), Anxiety in the Elderly:  Treatment and Research. New York:  Springer.  
Chawistiak, L., Rosenheck, R., McEvoy, J., Keefe, R., Swartz, M., & Lieberman, J. 
(2006). Interrelationships of psychiatric symptom severity, medical comorbidity, 
and functioning in schizophrenia. Psychiatric Services, 57, 8, 1102-1109. 
Chorpita, B., Albano, A., & Barlow, D. (1997). The structure of negative emotions in a 
clinical sample of children and adolescents. Journal of Abnormal Psychology, 
107, 1, 74-85. 
Cook, J., Orvaschel, H., Simco, E., Hersen, M., & Joiner, T. (2004). A test of the 
tripartite model of depression and anxiety in older adult psychiatric outpatients. 
Psychology and Aging, 19, 3, 444-451. 
Farley, L., & Hill, C. (2005). Parent psychological functioning, illness severity, and 




Palmer, William Michael, 2007, UMSL      p. 45 
Farrell, P. (1997). Psychological disorders and medical illness in the elderly:  A double-
edged sword. In L. VandeCreek, S. Knapp, & T. Jackson (Eds.), Innovations in 
Clinical Practice: A Sourcebook (Vol. 15). Sarasota, FL:  Professional Resource 
Press. 
Flint, A. (1999). Anxiety disorders in late life. Canadian Family Physician, 45, 2672-
2679. 
Forsell, Y., & Winblad, B. (1998). Feelings of anxiety and associated variables in a very 
elderly population. International Journal of Geriatric Psychiatry, 13, 454-458.   
Goldberg, D., & Williams, P. (1988). A user’s guide to the General Health 
Questionnaire. Windsor, UK:   NFER-Nelson Publishing 
Gurian, B., & Miner, J. (1991). Clinical presentation of anxiety in the elderly. In C. 
Salzman & B. Lebowitz (Eds.), Anxiety in the Elderly:  Treatment and Research. 
New York:  Springer.  
Haringsma, R., Engels, G., Beekman, A., & Spinhoven, P. (2004). The criterion validity 
of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample 
of self-referred elders with depressive symptomatology. International Journal of 
Geriatric Psychiatry, 19, 6, 558-563. 
Harter, M., Conway, K., & Merikangas, K. (2003). Associations between anxiety 
disorders and physical illness. European Archives of Psychiatry and Clinical 
Neuroscience, 253, 6, 313-320. 
Hersen, M., van Hasselt, C., & Gorenczy, A. (1993). Behavioral assessment of anxiety in 
older adults. Behavior Modification, 17, 2, 99-112. 
House, A., & Stark, D. (2002). ABC of psychological medicine:  Anxiety in medical 
patients. British Medical Journal, 325, 207-209. 
Palmer, William Michael, 2007, UMSL      p. 46 
Hu, L., & Bentler, P. (1995). Evaluating model fit. In Hoyle, R. (Ed.), Structural 
Equation Modeling:  Concepts, issues, and applications. Thousand Oaks, CA:  
Sage. 
Hybels, C., & Blazer, D. (2003). Epidemiology of late-life mental disorders. Clinics in  
Geriatric Medicine, 19, 663-696. 
Joiner, T. (1996). A confirmatory factor-analytic investigation of the tripartite model of 
depression and anxiety in college students. Cognitive Therapy and Research, 20, 
521-539. 
Joiner, T., Catanzaro, S., & Laurent, J. (1996). Tripartite structure of positive and 
negative affect, depression, and anxiety in child and adolescent psychiatric 
inpatients. Journal of Abnormal Psychology, 105, 401-409.  
Jolly, J., Dyck, M., Kramer, T., & Wherry, J. (1994). Integration of positive and negative 
affectivity and cognitive content-specificity:  Improved discrimination of anxious 
and depressive symptoms. Journal of Abnormal Psychology, 103, 3, 544-552. 
Kessler, R., McGonagle, K., Zhao, S., Nelson, C., & Hughes, M. (1994). Lifetime and 
12-month prevalence of DSM-III-R psychiatric disorders in the United States:  
Results from the National Comorbidity Survey. Archives of General Psychiatry, 
15, 8-19.  
Kiernan, G., Laurent, J., Joiner, T., Catanzaro, S., & MacLachlan, M. (2001). Cross-
cultural examination of the tripartite model with children:  Data from the 
Barretstown studies. Journal of Personality Assessment, 77, 2, 359-379. 
Kim, H., Braun, U., & Kunik, M., (2001). Anxiety and depression in medically ill older 
adults. Journal of Clinical Geropsychology, 7, 2, 117-130. 
Palmer, William Michael, 2007, UMSL      p. 47 
Krueger, R., Markon, K., Chentsova-Dutton, Y., Goldberg, D., & Ormel, J. (2003). A 
cross-cultural study of the structure of comorbidity among common 
psychopathological syndromes in the general health care setting. Journal of 
Abnormal Psychology, 112, 3, 437-447. 
Lauderdale, S., & Sheikh, J. (2003). Anxiety disorders in older adults. Clinics in 
Geriatric Medicine, 19, 721-741.  
Lawton, P., Kleban, M., & Dean, J. (1993). Affect and age:  Cross-sectional comparisons 
of structure and prevalence. Psychology and Aging, 8, 2,  163-175. 
Lecrubier, Y., Sheehan, D., Weiller, E., Amorim, P., Bonora, I., Sheehan, K., Janavs, J., 
& Dunbar, G. (1997). The Mini International Psychiatric Interview (MINI):  A 
short diagnostic structured interview—Reliability ands validity according to the 
CIDI. European Psychiatry, 12, 224-231. 
Lenze, E., Mulsant, B., Shear, K., Alexopoulos, G., Frank, E., & Reynolds, C. (2001). 
Comorbidity of depression and anxiety disorders in later life. Depression and 
Anxiety, 14, 86-93.  
Lenze, E., Shear, K., Mulsant, B., & Reynolds, C. (2002). Anxiety disorders in late life:  
An evolving picture. CNS Spectrums, 7, 11, 805-810. 
Levkoff, S., Chen, H., Coakley, E., McDonel-Herr, E., Oslin, D., Katz, I., Bartels, S., 
Maxwell, J., Olsen, E., Miles, K., Costantino, G., & Ware, J. (2004). Design and 
sample characteristics of the PRISM-E multisite randomized trial to improve 
behavioral health care for the elderly. Journal of Aging and Health, 16, 1, 3-27. 
Palmer, William Michael, 2007, UMSL      p. 48 
Lewinsohn, P., Seeley, J., Roberts, R., & Allen, N., (1997). Center for Epidemiologic 
Studies Depression Scale (CES-D) as a screening instrument for depression 
among community-residing older adults. Psychology and Aging, 12, 277-287. 
Linn, B., Linn, M., & Gurel L. (1968). Cumulative Illness Rating Scale. Journal of the 
American Geriatrics Society, 16, 622–626. 
Lynch, T., Compton, J., Mendelson, T., Robins, C., & Krishnan, K. (2000). Anxious 
depression among the elderly: clinical and phenomenological correlates. Aging 
and Mental Health, 4, 3, 268-274. 
MacCallum, R., Browne, M., & Sugawara, H. (1996). Power analysis and determination 
of sample size for covariance structural modeling. Psychological Methods, 1, 2, 
130-149. 
Maser, J., & Cloninger, C. (1990). Comorbidity of mood and anxiety disorders. 
Washington, DC:  American Psychiatric Press.  
Meeks, S., Woodruff-Borden, J., & Depp, C. (2003). Structural differentiation of self-
reported depression and anxiety in late life. Journal of Anxiety Disorders, 17, 
627-646. 
Mineka, S., Watson, D., & Clark, L. (1998). Comorbidity of anxiety and unipolar mood 
disorders. Annual Review of Psychology, 49, 377-412.  
Morin, C., Landreville, P., Colecchi, C., McDonald, K., Stone, J., & Ling, W. (1999). 
The Beck Anxiety Inventory:  Psychometric properties with older adults. Journal 
of Clinical Geropsychology, 5, 1, 19-29. 
Palmer, William Michael, 2007, UMSL      p. 49 
Nguyen, C., Goldberg, J., & Skeikh, J. (1999). The geriatric patient. In D. Mostofsky & 
D. Barlow (Eds.), The Management of Stress and Anxiety in Medical Disorders. 
Needham Heights, MA:  Allyn & Bacon. 
Owens, K., Hadjistavropoulos, T., & Asmundson, G. (2000). Addressing the need for 
appropriate norms when measuring anxiety in seniors. Aging and Mental Health, 
4, 4, 309-314. 
Pontillo, D., Lang, A., & Stein, M. (2002). Management and treatment of anxiety 
disorders in the older patient. Clinical Geriatrics, 10, 10, 38-49. 
Radloff, L. (1977). The CES-D scale:  A self-report depression scale for research in the 
general population. Applied Psychological Measurement, 1, 385-401. 
Regier, D., Myers, J., Kramer, M., Robins, L., Blazer, D., Hough, R., Eaton, W., & 
Locke, B. (1984). The NIMH Epidemiologic Catchment Area program:  
Historical context, major objectives, and study population characteristics. 
Archives of General Psychiatry, 41, 934-941. 
Regier, D., Burke, J., & Burke, K. (1990). Comorbidity of affective and anxiety disorders 
in the NIMH Epidemiologic Catchment Area program. In J. Maser & C. R. 
Cloninger (Eds.), Comorbidity of Mood and Anxiety Disorders. Washington, DC:  
American Psychiatric Press.  
Rivas-Vasquez, R., Saffa-Biller, D., Ruiz, I., Blais, M., & Rivas-Vasquez, A. (2004). 
Current issues in anxiety and depression:  Comorbid, mixed, and subthreshold 
disorders. Professional Psychology:  Research and Practice, 35, 1, 74-83.  
Palmer, William Michael, 2007, UMSL      p. 50 
Roberts, J., & Gotlib, I. (1997). Temporal variability in global self-esteem and specific 
self-evaluation as prospective predictors of emotional distress:  Specificity of 
predictors and outcome. Journal of Abnormal Psychology, 106, 521-529 
Roy-Byrne, P., & Katon, W. (2000). Anxiety management in the medical setting:  
Rationale, barriers to diagnosis and treatment, and proposed solutions. In D. 
Mostofsky & D. Barlow (Eds.), The Management of Stress and Anxiety in 
Medical Disorders. Needham Heights, MA:  Allyn & Bacon. 
Sable, J., & Jeste, D. (2001). Anxiety disorders in older adults. Current Psychiatry 
Reports, 3, 302-307. 
Sanderson, W., Dinardo, P., Rapee, R., & Barlow, D. (1990). Syndrome comorbidity in 
patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal 
Psychology, 99, 3, 308-312.  
Shapiro, A., Roberts, J., & Beck, J. (1999). Differentiating symptoms of anxiety and 
depression in older adults:  distinct cognitive and affective profiles? Cognitive 
Therapy and Research, 23, 1, 53-74. 
Sheikh, J. (2003). Anxiety in older adults:  Assessment and management of three 
common presentations. Geriatrics, 58, 5, 44-45.  
Sheikh, J., Cassidy, E., Doriaswamy, P., Salomon, R., Hornig, M., Holland P., Mandel, 
F., Clary, C., & Burt, T. (2004). Efficacy, safety, and tolerability of sertraline in 
patients with late-life depression and comorbid medical illness. Journal of the 
American Geriatrics Society, 52, 86-92. 
 
Sheehan, D., Lecrubier, Y., Sheehan, K., Amorim, P., Janavs, J., Weiller, E., et al. 
(1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The 
Palmer, William Michael, 2007, UMSL      p. 51 
development and validation of a structured diagnostic psychiatric interview for 
DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl 20), 22-33, quiz 
34-57.  
Small, G. (1997). Recognizing and treating anxiety in the elderly. Journal of Clinical 
Psychiatry, 58 (suppl. 3), 41-47. 
Smith, T., & McMillan, B. (2001). A primer of model fit indices in structural equation 
modeling. Paper presented at the annual meeting of the Southwest Educational 
Research Association, February 1-3, 2001, New Orleans, LA. 
Sobell, L. C., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988). Reliability of a timeline 
method:  Assessing normal drinkers’ reports of recent drinking and a comparative 
evaluation across several populations. British Journal of Addiction, 83, 393-402 
Spitzer, R. L., Williams, J. B., Kroenke, K., Linzer, M., deGruy, F. V., III, Hahn, S. R., et 
al. (1994). Utility of a new procedure for diagnosing mental disorders in primary 
care. The PRIME-MD 1000 Study. Journal of the American Medical Association, 
272, 1749-1756. 
Stanley, M., & Beck, J. (2001). Anxiety disorders. In B. Edelstein (Ed.) Clinical 
Geropsychology. London:  Pergamon Press.  
Steer, R., Beck, A., Clark, D., & Beck, J. (1994). Psychometric properties of the 
Cognitions Checklist with psychiatric outpatients and university students. Clinical 
Assessment, 6, 67-70. 
Steiger, J., & Lind, J. (1980). Statistically-based tests for the number of common factors. 
Paper presented at the Psychometric Society annual meeting, Iowa City, IA. 
Palmer, William Michael, 2007, UMSL      p. 52 
Stein, M., Sherbourne, C., Craske, M., Means-Christensen, A., Bystrtsky, A., Katon, W., 
Sullivan, G., & Roy-Byrne, P. (2004). Quality of care for primary care patients 
with anxiety disorders. American Journal of Psychiatry, 161, 2230-2237. 
Teachman, B., Siedlecki, K., & Magee, J. (2007). Aging and symptoms of anxiety and 
depression:  Structural invariance of the tripartite model. Psychology and Aging, 
22, 1, 160-170. 
Tellegen, A. (1985). Structures of mood and personality and their relevance to assessing 
anxiety, with an emphasis on self-report. In A. Tuma & J. Maser (Eds.), Anxiety 
and the Anxiety Disorders. Hillsdale, NJ:  Erlbaum.  
Ullmann, J. (2001). Structural Equation Modeling (chapter). In B. Tabachnik & L. Fidell, 
Using Multivariate Statistics (4th Ed.). Needham Heights, MA:  Allyn and Bacon. 
Watson, D., Clark, L., & Carey, G. (1988). Positive and negative affectivity and their 
relation to anxiety and depressive disorders. Journal of Abnormal Psychology, 97, 
346-353.  
Watson, D., Clark, L., & Tellegen, A. (1988). Development and validation of brief 
measures of positive and negative affect:  The PANAS scales. Journal of 
Personality and Social Psychology, 54, 1063-1070. 
Watson, D., Clark, L., Weber, K., Assenheimer, J., Strauss, M., & McCormick, R. 
(1995). Testing a tripartite model: II. Exploring the symptom structure of anxiety 
and depression in student, adult, and patient samples. Journal of Abnormal 
Psychology, 104, 1, 15-25. 
Wetherell, J., Gatz, M., & Pedersen, N. (2001). A longitudinal analysis of anxiety and 
depressive symptoms. Psychology and Aging, 16, 2, 187-195.  
Palmer, William Michael, 2007, UMSL      p. 53 
Wetherell, J., & Gatz, M., (2004). The Beck Anxiety Inventory in older adults with 
generalized anxiety disorder. Journal of Psychopathology and Behavioral 
Assessment, 27, 1, 17-24. 
Zajecka, J. (1997). Importance of establishing the diagnosis of persistent anxiety. Journal 
of Clinical Psychiatry, 58 (Suppl. 3), 9-13.  
Zinbarg, R., Barlow, D., Liebowitz, M., Street, L., Broadhead, E., Katon, W., Roy-Byrne, 
P., Lepine, J., Teherani, M., Richards, J., Brantley, P., & Kraemer, H. (1994). The 
DSM-IV field trial for mixed anxiety-depression. American Journal of 
Psychiatry, 151, 8, 1153-1162.   
Zinbarg, R., & Barlow, D. (1996). Structure of anxiety and the anxiety disorders:  A 
hierarchical model. Journal of Abnormal Psychology, 105, 2, 181-193. 
Zung, W., Broadhead, W., & Roth, M. (1993). Prevalence of depressive symptoms in 
primary care. Journal of Family Practice, 37, 4.,337-344. 
 
 
Palmer, William Michael, 2007, UMSL      p. 54 
Table 1. Comparison of key demographic variables between final sample (N = 2,163) 
and participants excluded for missing data1 (n = 87) 
             
 
              Final sample  Excluded cases 
     __________________________________________ 
 




 Male             1,622 76.0     68     78.1 
 Female    513 24.0     19         21.9  
Age 
 65-74             1,295 59.9                60         69.3  
 75 +     868 40.1                    27         30.7 
Ethnicity3           
 White              1217 56.3                43         49.3  
 Black     512 23.7     28         32.5  
 Asian     107   4.9                      6           6.5 
 Hispanic    292 13.5                  8           9.1  
 Native American/Other/Refused   56   2.6                      2           2.6 
Marital Status2         
 Married/partnered            1089 50.6                39         45.3 
 Separated/divorced   440 20.4                14         16.0  
 Widowed    510 23.7                23         26.7  
 Never married    115   5.3                    11         12.0 
Education2 
 Less than high school   916 42.3     46         53.3  
 High school/GED   497 23.0                16         18.7  
 Some college or higher  740 34.2                    23         26.6 
Financial Status2          
 Cannot make ends meet  436 20.2                22         25.3  
 Enough to get by   977 45.2                    53         60.0  
 Comfortable    707 32.7                    12         13.3 
            
NOTE: 1- Exclusion based on missing responses to MINI question M1(“ Have you 
worried excessively or been anxious about several things over the past six months?”) 2-
Totals less than 2,163 due to option to refuse question. 3-  Total exceeds 2,163 because 
multiple responses were allowed.  
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Table 2. Comparison of key variables of interest between final sample (N = 2,163) and 
participants excluded for missing data (n = 87). 
________________________________________________________________________ 
 
            Confidence Intervals (95 %) 
                                                          ___________________________________________ 
 
        Final sample   Excluded cases 
                                                          ___________________________________________ 
 
Variable name    Low           High                     Low          High           
________________________________________________________________________ 
 
CES-D well-being   1.03       15.03   -0-     13.08 
 
CES-D somatic    -0-       12.78  0.31     21.51  
 
CES-D anhedonia    -0-       10.99    -0-     12.63 
 
CES-D dysphoria    -0-       16.77    -0-     21.14 
 
BAI anxious cognitions   -0-         8.58    -0-     21.40 
 
BAI somatic arousal    -0-       10.31    -0-     32.60 
 
MINI summed anxiety items   -0-       12.19   2.82     13.84 
 
MINI summed depression    -0-         9.89   1.72     10.62 
________________________________________________________________________ 
NOTE: CES-D—Center for Epidemiological Studies-Depression Scale; BAI—Beck 
Anxiety Inventory; MINI—Mini International Neuropsychiatric Interview.                                                        
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Table 3. Mini International Neuropsychiatric Interview (MINI) diagnostic modules. 




Module    Time Frame   DSM-IV Code  
Major Depressive Episode  Current (past two weeks) 296.20-296.26 
 With melancholic features     296.30-296.36 
Dysthymia    Current (two years)  300.4 
Suicidality    Current (past month)  
Manic Episode   Current/Past   296.00-296.06 
 Hypomanic Episode  Current/Past   296.80-296.89 
Panic Disorder   Current/Lifetime  300.01-300.21 
Agoraphobia    Current   300.22 
Social Phobia    Current (past month)  300.23 
Obsessive-Compulsive  Current (past month)  300.3 
PTSD     Current (past month)  309.81  
Alcohol Dependence   Past 12 months  303.9 
Alcohol Abuse   Past 12 months  305.00 
Substance Dependence  Past 12 months  304.00-.90/305.20-.90 
Substance Abuse   Past 12 months  304.00-.90/305.20-.90 
Psychotic Disorders   Lifetime/Current  295.10-295.90/297.1/ 
         297.3/293.81/293.82/ 
         293.89/298.8/298.9 
Mood disorder w/Psychotic Features Current   296.24 
Anorexia Nervosa   Current (past 3 months) 307.1 
Bulimia Nervosa   Current (past 3 months) 307.51 
Generalized Anxiety Disorder Current (past 6 months) 300.02 
Antisocial PD    Lifetime   301.7 
________________________________________________________________________ 
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Table 4. MINI item composition of observed variables. 
________________________________________________________________________ 
 
Variable    Items and descriptions 
________________________________________________________________________ 
 
MINI Positive Affect (MP)  E 2. In the past two weeks, have you been less   
     interested in most things, or less interested in things   
     you used to enjoy most of the time? 
           E 3 (d). Did you feel tired or without energy almost   
     every day? 
     F 3 (c). Did you feel tired or without energy? 
     H 2 (d).Did you feel tired or without energy almost   
     every day? 
 
MINI Negative Affect (MN)  E 1. Have you been consistently depressed or down,   
     most of the day, nearly every day, for the past two   
     weeks? 
     E 3 (e). Did you feel worthless or guilty almost   
     every day? 
     F 3 (d). Did you lose your self-confidence? 
          H 2 (e). Did you feel worthless or guilty almost   
     every day? 
 
MINI Physiological Arousal (MPA) L 4 (a). Skipping, racing, or pounding heart 
     L 4 (b). Sweaty or clammy hands 
     L 4 (c). Trembling or shaking 
       L 4 (d). Shortness of breath 
     L 4 (e). Choking or lump in throat 
     L 4 (f). Chest pain 
     L 4 (g). Nausea, stomach pain, diarrhea 
     L 4 (h). Dizziness 
     L 4 (l). Tingling or numbness in body parts 
     L 4 (m). Hot or cold sensations 
 
MINI Non-specific Anxiety (MNX)  L 4 (i). Feelings of unreality or detachment 
     L 4 (j). Losing control or “going crazy” 
     L 4 (k). Fear of dying 
     M 1  Excessive worry 
     M 2  Difficult to control worrying 
     M 3 (a). Restless, keyed-up, on edge 
     M 3 (b). Tense 
 
MINI Depression (MD)   Sum of items in Modules E, F, H 
 
MINI Anxiety (MX)   Sum of items in Modules L, M 
________________________________________________________________________ 
NOTE: Module E—Major Depression and depression symptoms; Module F—Dysthymia; 
Module H—Depression history; Module L—Panic disorder; Module M—Generalized 
anxiety 
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Table 5. Medical history checklist from PRISM-E baseline (N = 2,163). 
________________________________________________________________________ 
 
Disease category          n     % 
________________________________________________________________________ 
 
Diabetes        546   25.2 
Hypertension      1389   64.2 
Heart trouble        756   35.0 
Vascular disease or atherosclerosis     711   32.9 
Any type of paralysis         93     4.3 
Any effects of stroke       162     7.5 
Arthritis      1385   65.1 
Stomach ulcer        231   10.7  
COPD, emphysema, asthma      385   17.8 
Glaucoma        315   14.6 
Liver disease          87     4.0 
Gall bladder          78     3.6 
Kidney disease       202     9.3 
Bladder problem       430   19.9 
Hip fracture          34     1.6 
Other fractures       130     6.0 
Anemia        155     7.2   
Parkinson’s disease         43     2.0 
Sleep problems     1157   53.5 
Skin disorders        573   26.5 
Cancer         262   12.1 
________________________________________________________________________ 
NOTE: Frequencies, percentages not cumulative. 
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Table 6. Mean ratings of severity, threat, chronicity, and progressiveness for disease 
categories, from survey of MSN students (N = 63) 
________________________________________________________________________ 
  
Disease category               Severity           Threat            Chronicity           Progressiveness  
______________________________________________________________________________________ 
 
            M          SD        M      SD          M        SD              M          SD 
                                                ________________________________________________ 
 
Diabetes                                                  2.98       1.33     2.15    1.07       4.78      0.55           3.53        1.13  
Hypertension                                    2.37      1.09    2.50    1.20        4.50      0.87           3.02        1.20 
Heart trouble         3.65      1.15     3.90    1.05        4.68       0.62          3.67        1.08 
Vascular disease or atherosclerosis       3.03      1.10     2.97    1.10        4.22       0.96           3.55        1.08    
Any type of paralysis                             3.72      1.41     2.17    1.22         4.15       1.27          2.62        1.33 
Any effects of stroke                              4.23      0.96     3.35    1.15         4.05       0.98          2.70        1.20   
Arthritis                                     1.72     1.07      1.38    0.90         4.18      1.12    3.78        1.19  
Stomach ulcer         1.87      0.85     1.45     0.81        2.67      1.17           1.97        0.88   
COPD, emphysema, asthma       3.78     1.03      3.75    1.07         4.50      0.81           4.12        0.98    
Glaucoma                                               1.47     0.70      1.22     0.52         3.03      1.56          2.50        1.95  
Liver disease            3.40     1.12     3.40    1.03         4.02      1.03    3.67        1.05      
Gall bladder         2.93     1.29       1.68    0.83         2.10      1.02           2.07        1.07      
Kidney disease                       3.62     1.07       3.13    1.20         3.97      1.16          3.63        1.19  
Bladder problem                       2.13     1.05       1.55    0.81         2.53      1.08          2.30        1.10    
Hip fracture          4.00     1.25       1.97   1.08          2.80      1.27          2.03       1.17      
Other fractures          2.80     1.37       1.58   0.94          2.10      1.10          1.53       0.89    
Anemia           2.27     1.23       1.77    0.90          2.95      1.37          2.03       1.12  
Parkinson’s disease         2.97     1.34       2.28   1.37          4.32      1.08          4.12       1.24  
Sleep problems          1.63     0.92       1.27   0.63          2.55      1.38          2.03       1.06  
Skin disorders                       1.47     0.82       1.25   0.65          2.30      1.38          1.98       1.14 
Cancer                                                   4.30     1.01       4.18   0.92          4.45      0.93          3.68       1.14  
Cataracts          1.40     0.74       1.21   0.64          2.50     1.35           2.42       1.38 
________________________________________________________________________ 
NOTE: Severity ratings—1= 0-20 % likelihood of hospitalization, 2 = 21-40 % 
likelihood, 3 = 41-60 % likelihood, 4 = 61-80 % likelihood, 5 = 81-100% likelihood; 
Threat Ratings--1 = 0-20 % likelihood of death, 2 = 21-40% likelihood, 3 = 41-60 % 
likelihood, 4 = 61-80 % likelihood, 5 = 81-100% likelihood; Chronicity Ratings--1 = 0-
20 % likelihood of continued illness, 2 = 21-40% likelihood, 3 = 41-60 % likelihood, 4 = 
61-80 % likelihood, 5 = 81-100% likelihood;  Progressiveness Ratings--1 = 0-20 % 
likelihood of increasing severity, 2 = 21-40% likelihood, 3 = 41-60 % likelihood, 4 = 61-
80 % likelihood, 5 = 81-100% likelihood. 
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Table 7. Intercorrelations for observed variables for all models. 
________________________________________________________________________ 
    1       2       3       4       5       6       7       8       9       10       11       12        
________________________________________________________________________ 
1.   BAC   --              
2.   BS  .78      -- 
3.   MX            .65     .59     -- 
4.   MPA          .26     .27   .60     -- 
5.   MNX         .23     .20   .54    .55     -- 
6.   MD            .26     .24   .28    .12    .09    -- 
7.   MP            .18     .19   .19     .06    .051  .79     -- 
8.   MN           .24     .22    .21    .06    .032  .74    .50     -- 
9.   CS             .31     .30   .28     .12   .10    .71    .63    .55     --                             
10. CA             .23     .22   .24     .08   .07    .61    .50    .55    .57      --                         
11. CD             .31     .25   .27     .11   .11    .67    .54    .65    .73     .65      -- 
12. CW          -.23    -.22 -.24    -.08  -.07  -.61   -.50   -.55  -.58  -1.00   -.65      --          
________________________________________________________________________ 
NOTE:  1—p < .05; 2—Non-significant. All other correlations significant at p < .01. 
BAC—BAI anxious cognitions; BS—BAI somatic; MX—MINI summed anxiety; MPA—
MINI physiological arousal; MNX—MINI non-specific anxiety; MD—MINI summed 
depression; MP—MINI positive affect; MN—MINI negative affect: CS—CES-D somatic; 
CA—CES-D anhedonia; CD—CES-D dysphoria; CW—CES-D well-being. 
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Table 8. Descriptive statistics for study variables (N =2163). 
________________________________________________________________________ 
 
              Range 
        ________________________ 
 
Variable name     M                SD                    Low          High           
________________________________________________________________________ 
 
CES-D well-being   8.04         3.58  -0-     12.00 
 
CES-D somatic   7.40         5.40  -0-     21.00  
 
CES-D anhedonia   3.96         3.58  -0-     12.00 
 
CES-D dysphoria   6.19         5.41  -0-     21.00 
 
BAI anxious cognitions  1.90         3.42  -0-     20.00 
 
BAI somatic arousal    3.80         6.53  -0-     31.00 
 
MINI physiological arousal   0.36            1.52                     -0-           10.00 
 
MINI nonspecific anxiety   0.12            0.74                     -0-             7.00 
 
MINI positive affect                            1.29            0.87                     -0-             3.00 
 
MINI negative affect                           0.82            0.80                     -0-             3.00 
 
MINI summed anxiety items   2.45         3.72  -0-     22.00 
 
MINI summed depression    4.44         2.78  -0-     17.00 
________________________________________________________________________ 
NOTE: CES-D—Center for Epidemiological Studies-Depression Scale; BAI—Beck 
Anxiety Inventory; MINI—Mini International Neuropsychiatric Interview.                                                        
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Table 9. Fit indices for measurement models with full PRISM-E sample (N = 2,163). 
________________________________________________________________________ 
     Model              χ2          df            χ2/df           GFI            AGFI            RMSEA 
________________________________________________________________________ 
 
Tripartite         10.397*      3           3.466          0.998          0.989              0.034 
Burns-Eidelson      588.542**  33        17.835          0.955          0.910              0.082 
Hierarchical         21.255**     5          4.251          0.997          0.986              0.039 
________________________________________________________________________ 
NOTE:  *  p < 0.05; ** p < 0.01.   
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Table 10. Fit indices for structural models with full PRISM-E sample (N = 2,163). 
________________________________________________________________________ 
     Model              χ2          df            χ2/df           GFI            AGFI            RMSEA 
________________________________________________________________________ 
 
Tripartite1         10.397*      3           3.466          0.998          0.989              0.034 
Burns-Eidelson    5489.248**  34      161.449          0.750          0.596              0.272 
Hierarchical         22.737**     6          3.790          0.997          0.988              0.036 
________________________________________________________________________ 
NOTE:  *  p < 0.05; ** p < 0.01. 1Statistics for this model are same as for measurement 
model, since all latent variables are first-order.   
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Table 11. Fit test summary for invariance between low and high medical illness 
severity/threat subsamples.  
________________________________________________________________________ 
 
Model description                              χ2               df               ∆χ2               ∆df               p 
________________________________________________________________________ 
 
1. Hypothesized baseline model    36.437          12               ---                 ---              --- 
 
2. Factor loadings, variances 
    and covariances constrained     260.308         21          223.871              9             0.0001 
    equal   
 
3. Factor loadings constrained       55.667          16            19.230              4             0.0007  
    equal      
 
4. Depression factor loadings        36.474          13              0.037              1                NS 
    constrained equal     
 
5. Depression factors, plus all  
    anxiety factors except BS           41.882          15              5.445              3                NS           
    constrained equal     
 
6. Depression factors, plus all  
    anxiety factors except MX          54.924          15            18.487              3             0.0003           
    constrained equal     
 
7. Depression factors, plus all  
    anxiety factors except BAC         51.153          15            14.716              3            0.0021           
    constrained equal  
________________________________________________________________________ 
NOTE:  ∆χ2  = difference in χ2 values. ∆df  = difference in degrees of freedom. All 
comparisons to Model 1.    
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Table 12. Fit test summary for invariance between low and high medical illness 
chronicity/progressiveness subsamples.  
________________________________________________________________________ 
 
Model description                              χ2               df               ∆χ2               ∆df               p 
________________________________________________________________________ 
 
1. Hypothesized baseline model    36.281          12               ---                 ---              --- 
 
2. Factor loadings, variances 
    and covariances constrained     278.582         21          242.300              9             0.0001 
    equal   
 
3. Factor loadings and latent          98.143          18            61.862              6             0.0001                     
    paths constrained equal      
 
4. Anxiety factor loadings and       76.409          17            40.128              1             0.0001 
    latent paths constrained equal     
 
5. Depression factor loadings  
    and latent paths                           41.882          15              5.445              3            0.0001           
    constrained equal     
 
6. Depression factors only              36.482          13              0.539              3               NS           
    constrained equal     
 
7. Depression factors, plus all  
    anxiety factors except BAC         50.540          15            14.259              3            0.0026           
    constrained equal  
 
8. Depression factors, plus all  
    anxiety factors except MX           55.023          15            18.742              3            0.003           
    constrained equal  
 
9. Depression factors, plus all  
    anxiety factors except BS            39.946          15               3.665              3              NS           
    constrained equal  
________________________________________________________________________ 
NOTE:  ∆χ2  = difference in χ2 values. ∆df  = difference in degrees of freedom. All 
comparisons to Model 1.    
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NOTE:  All paths are significant p < .01. CW—CES-D ‘well-being’ items; MP—MINI 
‘positive affect’ items; CD—CES-D ‘dysphoria’ items; BAC—BAI ‘anxious cognition’s 
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NOTE:  All paths significant at p < .01. CS—CES-D somatic items; CA—CES-D 
anhedonia items; MP—MINI items indicating positive affect; MD—MINI summed 
depression items; CD—CES-D dysphoria items; MN—MINI negative affect items; BAC—
BAI anxious cognitions items; MX—MINI summed anxiety items; MNX—MINI non-
specific anxiety items; BS—BAI somatic arousal items; MPA—MINI items indicating 
physiological arousal. 
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NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
items; BAC—BAI anxious cognitions; MX—MINI anxiety items; BS-BAI somatic arousal; 
CS—CES-D somatic. 
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NOTE:  All paths significant at p < .01. CS—CES-D somatic items; CA—CES-D 
anhedonia items; MP—MINI items indicating positive affect; MD—MINI summed 
depression items; CD—CES-D dysphoria items; MN—MINI negative affect items; BAC—
BAI anxious cognitions items; MX—MINI summed anxiety items; MNX—MINI non-
specific anxiety items; BS—BAI somatic arousal items; MPA—MINI items indicating 
physiological arousal. 
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Figure 5. Structural model for hierarchical model (Meeks et al., 2003). 
 
 
NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
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Figure 6.  Hierarchical model displaying correlations for regression paths-high 





NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
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Figure 7. Hierarchical model displaying correlations for regression paths-low 
severity/threat sample (n = 705).   
 
 
NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
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 Figure 8. Hierarchical model displaying correlations for regression paths-high 





NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
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Figure 9.  Hierarchical model displaying correlations for regression paths-low 
chronicity/progressiveness sample (n = 716). 
 
NOTE:  All paths significant at p < .01. CW—CES-D well-being; MD—MINI depression 
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Appendix 
ILLNESS PERCEPTIONS SURVEY 
 
Thank you for participating in this survey. We are interested in your perceptions, as a 
healthcare provider, of the severity, threat level, chronicity, and progressiveness of a 
number of diagnostic categories commonly observed in older adults. For this survey, the 
term ‘older adults’ will be defined as age 65 or older. 
 
Severity is defined as the likelihood that a person suffering from this condition would 
require one or more days of hospitalization. For each category, use the following rating 
scale: 
   1 = 0-20 % likelihood of hospitalization 
   2 = 21-40 % likelihood 
   3 = 41-60 % likelihood 
   4 = 61-80 % likelihood 
   5 = 81-100% likelihood 
 
Threat level is defined as the likelihood that sequelae of diseases in this category would 
result in the death of the patient. For each category, use the following scale: 
   1 = 0-20 % likelihood 
   2 = 21-40% likelihood 
   3 = 41-60 % likelihood 
   4 = 61-80 % likelihood 
   5 = 81-100% likelihood  
 
Chronicity is defined as the likelihood that the disease will require medical treatment, 
beyond that which the patient could independently manage, for 6 months or longer. 
 For each category, use the following scale: 
   1 = 0-20 % likelihood 
   2 = 21-40% likelihood 
   3 = 41-60 % likelihood 
   4 = 61-80 % likelihood 
   5 = 81-100% likelihood 
 
Progressiveness is defined as the likelihood that diseases in this category will increase in 
severity over time, regardless of treatment. For each category, use the following scale: 
   1 = 0-20 % likelihood 
   2 = 21-40% likelihood 
   3 = 41-60 % likelihood 
   4 = 61-80 % likelihood 
   5 = 81-100% likelihood 
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Disease category    Severity      Threat     Chronicity    Progressiveness 
Diabetes     _____     _____      _____           _____  
Hypertension    _____     _____      _____           _____  
Heart disease      _____     _____      _____           _____  
Vascular disease  
(peripheral or atherosclerosis)  _____     _____      _____           _____ 
   
Paralysis (any etiology)   _____     _____      _____           _____ 
Stroke     _____     _____      _____           _____ 
Arthritis     _____     _____      _____           _____ 
Stomach ulcer    _____     _____      _____           _____ 
COPD     _____     _____      _____           _____ 
Glaucoma     _____     _____      _____           _____ 
Cancer     _____     _____      _____           _____ 
Cataracts     _____     _____      _____           _____ 
Liver disease    _____     _____      _____           _____        
Gall bladder    _____     _____      _____           _____ 
Kidney disease    _____     _____      _____           _____ 
Bladder problems    _____     _____      _____           _____    
Hip fracture    _____     _____      _____           _____ 
Other fractures    _____     _____      _____           _____ 
Anemia     _____     _____      _____           _____ 
Parkinsons’ disease       _____     _____      _____           _____   
Sleep disorders    _____     _____      _____           _____  
Skin conditions    _____     _____      _____           _____ 
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Please answer the following demographic questions. 
1. What is your age? 
1 = 18-30 
2 = 31-40 
3 = 41-50 
4 = 51-60 
5 = < 60 years 
 
2. What is your level of clinical experience? 
1 = 0-1 years 
2 = 1-5 years 
3 = 5-10 years 
4 = 10-15 years 
5 = < 15 years 
 
3. What is your identified race/ethnicity? (optional—for research purposes only) 
1 = African-American/Native African 
2 = Asian/Pacific Islander 
3 = Caucasian/European 
4 = Latin American/Hispanic 
5 = Native American/Alaskan 
6 = Biracial or multiracial 
 
4. What is your identified gender? (optional—for research purposes only) 
1 = Male  
2 = Female 
 
